Jenscare Scientific Co. Ltd. will be attending the 2025 West China Minimally Invasive Cardiovascular Congress and the Eighth West China Valve Forum. At this event, they successfully completed a number of live-streaming operation cases related to their Ken-Valve, a transcatheter aortic valve replacement product.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.